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Background: Clear cell sarcoma (CCS), also known as malignant melanoma of soft parts, is a rare type of soft tissue
sarcoma which exhibits morphological, immunohistochemical and ultrastructural similarity with malignant
melanoma. It is rarely localized in the intestine and the natural history of this tumor is not yet clear.
Case report: A 49-year-old woman presented with diffuse abdominal colicky pain and vomitus over the previous
seven days. An X-ray of the abdomen revealed obstruction of the small intestine. The patient underwent contrast
enhanced abdominal computerized tomography (CT), which confirmed the obstruction at the jejunum and an
associated circumferential wall thickening extending about 3 cm in length, causing concentric narrowing of the
lumen. At laparotomy, a mass was recognized at the level of the jejunum in the small intestine, which caused
almost complete obstruction of the lumen. At the point of obstruction, adhered loops of small intestine were
found. A segmental small bowel resection was performed with 5 cm clear margins and its respective mesenteric
lymph nodes.
Results: Histological examination of the specimen revealed a tumor (3×3×2cm) with epithelioid cell characteristics
and eosinophilic or clear cytoplasm and focal translucent nuclei. Immunohistochemistry was positive for S100,
epithelial membrane antigen (EMA) and synaptophysin. The tumor was pankeratin AE1/AE2, GFAP, HMB45 and
MART-1/Melan-A negative. Twelve lymph nodes were retrieved and were free of neoplastic infiltration. Cytogenetic
examination revealed translocation of the EWSR1 gene. The patient had an uncomplicated postoperative course
and left the hospital seven days after her admission in good general condition. After 20 months of follow-up the
patient remains asymptomatic without any clinical or radiological evidence of recurrence.
Conclusion: CCS sarcoma can be rarely localized in the jejunum. Due to its morphological similarity to malignant
melanoma, cytogenetic examination is necessary for its diagnosis. Wide resection of the tumor and its respective
lymph nodes was associated with a 20-month disease free survival in this patient.
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Clear cell sarcoma (CCS) is a rare type of soft tissue
sarcoma, originally described by Enzinger in 1965 [1].
The main characteristic of CCS is its morphological, im-
munohistochemical and ultrastructural similarity to malig-
nant melanoma [2]. However, CCS is genetically distinct
from melanomas as it lacks BRAF mutations [3] and in the
majority of cases it harbors a chromosomal translocation
t(12;22)(q13;q12), which leads to the formation of the
EWS/ATF1 fusion transcript [4]. The tumor typically arises* Correspondence: kwstaslasith@yahoo.gr
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distribution, and reproduction in any mediumin the distal extremities of young adults involving, almost
always, tendons and aponeuroses. Gastrointestinal (GI)
tract involvement, as the primary site has rarely been
reported in the literature [5]. Thus, the natural history and
the exact prognosis of these tumors are not yet clear.
Herein we present a case of CCS of the jejunum and its
20-month follow-up.Case presentation
A 49-year-old female patient presented to the emergency
department with a seven-day history of diffuse abdominal
colicky pain and continuous vomiting. On clinical examin-
ation, the abdomen was distended, exhibiting metallic
bowel sounds. An X-ray was performed which indicated ob-
struction of the small intestine. Computerized tomographyntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 2 Tumor infiltrates the small bowel (hematoxylin-eosin
staining × 40).
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centric wall thickening, measuring 3 cm.
The patient underwent emergency midline laparotomy
and a circumferential-eccentric wall thickening of nodu-
lar formation was recognized at the level of the jejunum
in the small intestine, causing concentric narrowing of
the lumen. At the point of obstruction, adhered loops of
small intestine were found (Figure 1). Partial excision of
the upper ileum with side-to-side jejuno-ileal anasto-
mosis was performed.
Pathological examination of the resected small bowel
specimen revealed a 3 × 2 × 3 cm tumor. The micro-
scopic examination showed an epithelioid neoplasm
which was diffusely infiltrating the bowel wall in sheets
and nests. The tumor cells had eosinophilic or clear
cytoplasm and vesicular nuclei. In some areas, nuclei
with nucleoli were observed. The mitotic rate was ap-
proximately eight mitoses per 10 high power fields
(Figures 2 and 3). The immunohistochemical profile of
the tumor was positive for S-100 protein (Figure 4), fo-
cally positive for epithelial membrane antigen (EMA)
and weakly positive for synaptophysin at some locations
and negative for pankeratins AE1/AE2, GFAP, HMB45
and MART-1. EWRS1 gene rearrangement was observed
during cytogenetic analysis and 12 out of 12 excised
lymph nodes were free from neoplastic infiltration.
The patient had an uncomplicated post-operative
course and left in good general condition after seven
days of hospitalization. Twenty months post-operatively
the patient remains asymptomatic and has no clinical
manifestation of the disease.
Discussion
Clear cell sarcoma is a rare type of malignancy, that
shows features of melanocytic differentiation and most
commonly affects tendons and aponeuroses of the distalFigure 1 Macroscopic views of the resected small bowel, where the t
small bowel loop. (B) Intraluminal view, where the tumor causes circumfere
concentric luminal narrowing.extremities, particularly the foot and ankle (43%) and
the knees, wrists and hands. Typically it presents as a
slow growing tumor. In rare occasions it primarily
affects the gastrointestinal tract [5]. A total of 21 GI
CCS cases have been reported in the literature, more
often arising in the ileum (10 cases) and less commonly
in other sites, such as the jejunum (six cases) the duode-
num (one case), the stomach (one case) and the colon
(three cases). The present one is the seventh well-
documented case of CCS arising in the jejunum reported
in the literature. The median size of the reported cases
is 5 cm and the average age of the patients at diagnosis
is 39 years old [6]. A slight female predominance has
been observed (male over female ratio is about 0.8).
These characteristics are similar to the CCS of tendons
and aponeuroses as presented in one of the largest and
latest series [7].umor is noted (arrow). (A) Tumor causing adhesion of the adjacent
ntial-eccentric wall thickening of nodular formation, and thus
Figure 3 Clear cell sarcoma. Nests of epithelioid cells with
eosinophilic or clear cytoplasm (hematoxylin-eosin staining × 200).
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struction, anemia or gastrointestinal bleeding [8]. Usu-
ally the patient is managed at an emergency setting due
to intestinal obstruction, making surgical excision of the
tumor the first step in its diagnosis and treatment. At
laparotomy, GI CCS tumors typically appear as ulcerated
masses involving the intestinal wall layers in full thick-
ness. In some cases, though, the gross appearance is that
of a polypoid lesion.
The pathological diagnosis of CCS in the gastrointes-
tinal tract is often difficult, due to the inconsistent ex-
pression of melanocytic markers and its unusual site of
presentation [6], requiring more than one approach. The
common histologic features are similar to CCS affecting
the tendons and aponeuroses. Usually the tumor consists
of fascicles of small rounded cells which are separated
by fibrous septa. They have abundant clear or eosino-
philic cytoplasm and vesicular nuclei with prominentFigure 4 Neoplasmatic cells with positive expression of S-100
protein (S-100 staining × 100).nucleoli. However, the majority of cases of CCS of the
soft parts are characterized by expression of melanocytic
markers (HMB45, A103, MITF and so on) more often
than gastrointestinal CCS, where most tumors are nega-
tive for these markers [4]. In addition, a histologic vari-
ant of gastrointestinal CCS has been described, where
the presence of scattered osteoclast-like multinucleated
giant cells is the dominant feature [9]. Thus, there is not
a general agreement on the histological profile of GI
CCS. However, there are immunohistochemical charac-
teristics that may provide clues to the differential diag-
nosis of the tumor. Strong S-100 protein positivity
points to the exclusion of a gastrointestinal stromal
tumor (GIST) [10], which accounts for most of the mes-
enchymal tumors at this site. In addition, the presence
of EWS-ATF1 fusion transcript [3], resulting from a
chromosomal translocation t(12;22)(q13;q12), when de-
monstrated in cytogenetic analysis is the only reliable
marker for differentiating CCS from malignant melan-
oma, since most morphological, immunohistochemical
and ultrastructural features are similar.
In CCS of tendons and aponeuroses, the commonly
accepted management is wide surgical resection of the
tumor with or without adjuvant radiotherapy. Metastatic
tumors exhibit almost no response to systemic chemo-
therapy, as shown in a retrospective study of 24 cases
[11]. However, there is no consensus on the manage-
ment of GI CCS and most of the details about the man-
agement of these patients are usually not reported. Our
case was managed based on the National Comprehen-
sive Cancer Network (NCCN) practice guidelines for
soft tissue sarcomas of the GI tract. The patient did not
receive any chemotherapy or radiotherapy and was sche-
duled for follow-up visits (including abdominal, thoracic
CT scanning) every three to six months.
Overall, GI CCS has an aggressive behavior, with a
high incidence of local (lymph node) and distal (most
commonly liver) metastasis. In 55% of the cases re-
ported, lymph node metastasis was present at the time
of diagnosis and only one case had metastasis to the
liver along with regional lymph node metastasis. During
the follow-up, liver metastasis developed in 32% of the
patients reported, 27% have died and only three patients
(14%) showed no evidence of the disease after the resec-
tion of the primary lesion. However, the detailed follow-
up is not reported in many cases, which possibly leads
to underestimation of the morbidity and mortality of the
disease. Overall, the behavior is consistent with CCS
of tendons and aponeuroses [12], although the latter
metastasizes more commonly to the lungs or bones, a
difference probably resulting from the different vascular
drainage of the two different primary sites. In this case,
however, all of the 12 lymph nodes resected were disease
free and at the 20-month postoperative follow-up, still
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small number of cases with adequate follow-up does not
allow the determination of specific prognostic factors.
Conclusion
Clear cell sarcoma of the gastrointestinal tract is a rare
neoplasm with poor prognosis. The diagnosis is based
on specific histological, immunohistochemical and genet
characteristics. The mainstream treatment is surgical re-
section of the tumor, while there is no evidence about the
effectiveness of adjuvant chemotherapy and radiotherapy.
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